South Asians and Europeans react differently to common drugs

October 14, 2011

(Medical Xpress) -- A University of Sydney PhD student has discovered the different diets and lifestyles of South Asians compared to Europeans could lead to the two groups requiring very different doses of medicines commonly used to treat illnesses such as depression and psychosis.

Vidya Perera, a final year PhD student in the Faculty of Pharmacy, has found that people from could need lower doses of these medicines because they are likely to have lower levels of CYP1A2, an enzyme that metabolises drugs.

"Vegetables such as cabbages, cauliflower and broccoli are known to increase levels of CYP1A2, as was demonstrated in this study and previous studies in people of European background. The lower levels of CYP1A2 in , however, appears to be due to the common practice of cooking these vegetables in curries using ingredients such as cumin and tumeric, ingredients known to inhibit the enzyme, overriding the effect of the vegetables," Mr Perera explained.

Mr Perera has just been declared the NSW winner of the AusBiotech/GlaxoSmithKline Student Excellence Awards as a result of his research.

"I started out looking for between the two groups to account for the differences in CYP1A2 activity. What was fascinating to discover is that genetic differences only accounted for 3 per cent of variability in CYP1A2 activity, while environment and accounted for 35 percent of the differences," Mr Perera said.

A total of 332 people took part in the study - 166 South Asians and 166 Europeans. CYP1A2 levels were measured by giving participants a caffeine tablet, and analysing CYP1A2 in saliva samples four hours later. Demographic, dietary and lifestyle information was obtained using a questionnaire.

"Most drugs are approved in clinical trials conducted in Europe and North America using healthy, middle-aged European men," Mr Perera explained. "This is the first study to look at CYP1A2 activity in South Asians. Understanding the correct dose of a medicine is crucial to achieving beneficial results and avoiding adverse drug reactions."

Professor Andrew McLachlan, Associate Dean (Research) in the Faculty of Pharmacy and Mr Perera's PhD supervisor, commented on the significance of this research.

"The development and testing of medicines is a global enterprise. The highest population growth is occurring in South Asia, yet we know relatively little about how to translate research findings between different populations of people."

"This research, for the first time, unpacks the complex interplay of factors that can affect how people breakdown and eliminate medicines from their body."

"Past research has attributed differences between people from different geographical regions to result from genetic differences. This important research highlights how dietary and cultural factors can impact on pharmacological response."

Mr Perera will travel to Adelaide this weekend to compete before a panel of judges in the national final of the AusBiotech/GlaxoSmithKline Student Excellence Awards. He will present his research on Sunday, with the winner to be announced on Monday.

AusBiotech 2011 is the annual conference of AusBiotech and the premier biotechnology and life sciences conference for Australia and the Asia-Pacific, attracting over 1400 delegates from across the world each year.

(GSK) is a global research-based pharmaceutical and healthcare company. It collaborates with local researchers and doctors to discover new ways of treating and preventing disease. Mr Perera is the recipient of the Peter Coates Postgraduate Scholarship in Ethnopharmacology, supported by GSK.

Explore further: Genetic variants associated with caffeine intake identified

Related Stories

Genetic variants associated with caffeine intake identified

April 6, 2011
Two genes in which variation affects intake of caffeine, the most widely consumed stimulant in the world, have been discovered. A team of investigators from the National Cancer Institute, Harvard School of Public Health, ...

Six new genetic variants linked to type 2 diabetes discovered in South Asians

August 28, 2011
An international team of researchers led by Imperial College London has identified six new genetic variants associated with type-2 diabetes in South Asians. The findings, published in Nature Genetics, give scientists new ...

'Sitting down’ risk for diabetes in South Asians regardless of exercise, waist size

May 10, 2011
For South Asians, time spent sitting down is a risk factor for diabetes which is not counteracted by time spent exercising or decreased waist size. These are the findings of a new study funded by the National Prevention Research ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.